Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/14/2026

Management of Upper Respiratory Infection with Sore Throat

Epidemiology & Natural History

  • Most acute sore throats are caused by viruses, are self‑limiting, and resolve within 7 days without antibiotics; symptomatic treatment with NSAIDs is recommended unless Group A Streptococcus (GAS) infection is confirmed. 1

Initial Assessment & Testing Strategy

  • The Infectious Diseases Society of America (IDSA) advises against empirical antibiotic prescription; a clinical score (Centor, McIsaac, or FeverPAIN) should be used first, and testing performed only when the score exceeds 3 points. 2
  • Children younger than 3 years do not require routine streptococcal testing because GAS pharyngitis and subsequent rheumatic fever are rare in this age group. 1
  • In children and adolescents with a negative rapid antigen detection test (RADT), a confirmatory throat culture is required owing to the higher risk of rheumatic fever. 1
  • In adults with a negative RADT, a backup throat culture is not necessary. 1

Symptomatic (Non‑Antibiotic) Treatment

  • First‑line analgesics for pain and fever are ibuprofen or naproxen (preferred NSAIDs); acetaminophen is an acceptable alternative. 1
  • Throat lozenges provide topical relief of sore‑throat discomfort. 2
  • Salt‑water gargles and viscous lidocaine are commonly used but lack robust supporting evidence. 2
  • Aspirin should be avoided in children because of the risk of Reye’s syndrome. 1

Antibiotic Therapy for Confirmed GAS Pharyngitis

First‑Line Regimens (No Penicillin Allergy)

  • Penicillin V (or amoxicillin) remains the preferred agents because of their narrow spectrum, low adverse‑event rates, low cost, and absence of documented GAS resistance to penicillin. 1

Alternative Regimens (Penicillin Allergy)

  • For patients with non‑anaphylactic penicillin allergy, first‑generation cephalosporins (e.g., cefalexin, cefadroxil) are recommended.
  • For patients with type I hypersensitivity or anaphylaxis, clindamycin or a macrolide (azithromycin or clarithromycin) may be used, but macrolide resistance exceeds 37 % in some regions, so these agents should be reserved for confirmed penicillin‑allergic patients. 1

Treatment Duration & Expected Outcomes

  • The IDSA standard duration is 10 days for most oral antibiotics (5 days for azithromycin). 1
  • Antibiotic therapy shortens symptom duration by only 1–2 days; the number needed to treat (NNT) is 6 patients to achieve benefit at 3 days and 21 patients at 1 week. 2
  • The principal benefit of antibiotics is prevention of complications (peritonsillar abscess, acute rheumatic fever) and reduction of bacterial transmission; antibiotics do not prevent acute glomerulonephritis. 2

Common Pitfalls & Contraindications

  • Overprescription: > 60 % of adults with sore throat receive unnecessary antibiotics. 2
  • Clinical prediction alone is insufficient to differentiate viral from bacterial pharyngitis; testing is required. [2][1]
  • Routine post‑treatment cultures are not indicated except in special circumstances (e.g., history of rheumatic fever, outbreak settings). 1
  • Asymptomatic household contacts should not be tested or treated because carriers have low transmission and complication risk. 1
  • Systemic corticosteroids are not recommended as adjunctive therapy for streptococcal pharyngitis. 1
  • Chronic GAS carriers experiencing recurrent viral upper‑respiratory infections do not benefit from repeated antibiotic courses. [2][1]

Antibacterial Management of Confirmed Streptococcal Pharyngitis

First‑Line Antibiotic Regimens (Patients without Penicillin Allergy)

  • Penicillin V oral – 250 mg 2–3 times daily for 10 days in children; 500 mg 2 times daily or 250 mg 4 times daily for 10 days in adolescents and adults. Strong recommendation, high‑quality evidence. 3
  • Amoxicillin oral – 50 mg/kg once daily (maximum 1000 mg) for 10 days; alternative 25 mg/kg twice daily (maximum 500 mg per dose) for 10 days. Strong recommendation, high‑quality evidence. 4
  • Benzathine Penicillin G intramuscular, single dose – 600 000 IU for patients < 27 kg; 1 200 000 IU for patients ≥ 27 kg. Strong recommendation, high‑quality evidence.

    Weight (kg) Dose (IU)
    < 27 600 000
    ≥ 27 1 200 000

    3

Alternative Regimens for Patients with Penicillin Allergy

  • Cefalexin oral – 20 mg/kg per dose twice daily (maximum 500 mg per dose) for 10 days; avoid in type I hypersensitivity to penicillins. 4
  • Cefadroxil oral – 30 mg/kg once daily (maximum 1 g) for 10 days; avoid in type I hypersensitivity to penicillins. 3
  • Clindamycin oral – 7 mg/kg per dose three times daily (maximum 300 mg per dose) for 10 days. 4
  • Azithromycin oral – 12 mg/kg once daily (maximum 500 mg) for 5 days. 3
  • Clarithromycin oral – 7.5 mg/kg per dose twice daily (maximum 250 mg per dose) for 10 days. 4

Rationale for Preferring Penicillin V/Amoxicillin

  • Narrow antimicrobial spectrum reduces impact on normal flora. 4
  • Low incidence of adverse drug reactions compared with broader‑spectrum agents. 3
  • Modest cost makes these agents economically favorable. 5

Macrolide Resistance Considerations

  • Geographically variable macrolide resistance in Streptococcus pyogenes; some regions report erythromycin resistance rates > 37 %. Macrolides should be reserved for confirmed penicillin‑allergic patients. 3

Adjunctive Symptomatic Therapy

  • Analgesics/antipyretics (e.g., acetaminophen or NSAIDs) are appropriate for moderate‑to‑severe pain or high fever. 6
  • Aspirin should be avoided in children due to risk of Reye’s syndrome. 5
  • Systemic corticosteroids are not recommended for routine treatment of streptococcal pharyngitis. 6
  • Do not initiate empiric antibiotics without laboratory confirmation (e.g., rapid antigen detection test or culture) because clinical features overlap with viral pharyngitis. 3
  • Routine post‑treatment throat cultures are not indicated; they should be reserved for specific clinical scenarios. 6
  • Asymptomatic carriers of S. pyogenes do not require treatment, given their low risk of transmission and complications. 4
  • Routine testing of children < 3 years is unnecessary; classic streptococcal pharyngitis and acute rheumatic fever are rare in this age group. 5